GlassScriptPhysician profile
Lilian Akuwa Ike
NPI 1851806574
$4,404.87
in general payments reported to CMS, 2019-2025
17 companies · $1,573 in 2025
The $1,573 reported for 2025 was more than what 89% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $882 · 2022: $169 · 2023: $839 · 2024: $942 · 2025: $1,573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,248 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,247.76 |
| Education | $106.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,347.97 | 2021-2025 | Invega Sustenna, Invega Trinza, Invega |
| Teva Pharmaceuticals USA, INC. | $610.43 | 2021-2025 | Uzedy |
| Alkermes, INC. | $416.20 | 2021-2025 | Aristada, Lybalvi, Aristada Initio |
| Otsuka America Pharmaceutical, INC. | $396.24 | 2021-2025 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Supernus Pharmaceuticals, INC. | $374.17 | 2024-2025 | Qelbree |
| Neurocrine Biosciences, INC. | $370.95 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $148.63 | 2025 | Cobenfy |
| Ironshore Pharmaceuticals INC. | $139.77 | 2021 | |
| Axsome Therapeutics, INC. | $138.09 | 2023 | Auvelity |
| Abbvie INC. | $115.59 | 2021-2024 | |
| Lundbeck LLC | $87.95 | 2021-2025 | Rexulti |
| Sunovion Pharmaceuticals INC. | $77.72 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $56.55 | 2021 | |
| Indivior INC. | $55.05 | 2021-2022 | |
| Almatica Pharma LLC | $25.92 | 2025 | Loreev Xr |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.05 | 2021 | |
| Noven Therapeutics, LLC | $20.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lilian Ike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.